Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Dec 30;70(6):893-903.
doi: 10.33549/physiolres.934743. Epub 2021 Oct 30.

Age-Related Progression of Microvascular Dysfunction in Cystic Fibrosis: New Detection Ways and Clinical Outcomes

Affiliations
Observational Study

Age-Related Progression of Microvascular Dysfunction in Cystic Fibrosis: New Detection Ways and Clinical Outcomes

M Kreslová et al. Physiol Res. .

Abstract

There are concerns about altered vascular functions that could play an important role in the pathogenesis and influence the severity of chronic disease, however, increased cardiovascular risk in paediatric cystic fibrosis (CF) has not been yet fully understood. Aim was to analyse vascular disease risk and investigate changes over times in CF and controls. We prospectively enrolled 22 CF subjects (a median age of 16.07 years), and 22 healthy demographically matched controls (a median age of 17.28 years) and determined endothelial function. We utilised a combined diagnostic approach by measuring the plethysmographic Reactive Hyperemia Index (RHI) as the post-to preocclusive endothelium-dependent changes of vascular tone, and biomarkers that are known to be related to endothelial dysfunction (ED): asymmetric dimethyl arginine (ADMA), high-sensitive CRP (hsCRP), VCAM-1 and E-selectin. RHI values were significantly lower in CF young adults (p<0.005). HsCRP (p<0.005), E-selectin (p<0.001) and VCAM-1 (p<0.001) were significantly increased in CF patients since childhood. The findings have provided a detailed account of the ongoing process of microvascular dysfunction with gradual progression with the age of CF patients, making them further at risk of advanced vascular disease. Elevations of biomarkers in CF children with not yet demonstrated RHI changes but with significantly reduced RHI in adulthood and lipid profile changes indicate the possible occurrence of ED with CF-related specific risk factors over time and will enable us to provide the best possible support.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

There is no conflict of interest.

Figures

Fig. 1
Fig. 1
RHI measurement. Comparison of healthy controls curves with normal endothelial function and CF patients with endothelial dysfunction. Upper curve with PAT amplitude recorded on control arm. Lower curve with PAT amplitude recorded on the examined arm with occlusion during the second phase and subsequent reactive hyperemia during the third phase of the examination. https://level1diagnostics.com/testing/
Fig. 2
Fig. 2
RHI in CF children 15–18 years vs CF adults. Boxes indicate the inter-quartile range. Horizontal lines within boxes indicate medians. Whiskers extend to the highest or lowest values; RHI - reactive hyperemic index; CF - cystic fibrosis
Fig. 3
Fig. 3
RHI in CF adults vs HC. Boxes indicate the inter-quartile range. Horizontal lines within boxes indicate medians. Whiskers extend to the highest or lowest values; RHI - reactive hyperemic index; CF - cystic fibrosis; HC - healthy controls
Fig. 4
Fig. 4
RHI in CF children and adults vs HC. Boxes indicate the inter-quartile range. Horizontal lines within boxes indicate medians. Whiskers extend to the highest or lowest values; RHI - reactive hyperemic index; CF - cystic fibrosis; HC - healthy controls

References

    1. ALLAN RB, DELANEY CL, MILLER MD, SPARK JI. A comparison of flow-mediated dilatation and peripheral artery tonometry for measurment of endothelial function in healthy individuals and patients with peripheral artrial disease. Eur J Vasc Endovasc Surg. 2013;45:263–269. doi: 10.1016/j.ejvs.2012.12.002. - DOI - PubMed
    1. AIRLEY RE, MONAGHAN JE, STRATFORD IJ. Hypoxia and disease: opportunities for novel diagnostic and therapeutic prodrug strategies. Pharm J. 2000;264:666–673.
    1. BECKER BF, JACOB M, LEIPERT S, SALMON AH, CHAPPELL D. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases. Br J Clin Pharmacol. 2015;80:389–402. doi: 10.1111/bcp.12629. - DOI - PMC - PubMed
    1. BONNETI PO, LERMAN LO, LERMAN A. Endothelial dysfunction - A marker of Atherosclerotic Risk. Arterioscler Thromb Vasc Bio. 2003;23:168–175. doi: 10.1161/01.ATV.0000051384.43104.FC. - DOI - PubMed
    1. BUEHLER T, STEINMANN M, SINGER F, REGAMEY N, CASAULTA C, SCHOENI MH, SIMONETTI GD. Increased arterial stiffness in children with cystic fibrosis. Eur Respir J. 2012;39:1536–1537. doi: 10.1183/09031936.00212511. - DOI - PubMed

Publication types